All Stories

  1. Amino acid metabolic alterations in subclinical hypothyroidism: Comparative analysis of plasma profiles in patients and healthy controls
  2. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of epilepsy: a systematic review and meta-analysis of clinical trials (from 1990 to 2025)
  3. Decline in HIV Prevalence Among People Who Inject Drugs in Iran
  4. Effectiveness of Psychological Interventions on People Living with HIV (PLWH): Representative Center, 20 Years Experience in Iran
  5. Efficacy and Safety of Tenofovir Disoproxil Fumarate Cessation in Chronic Hepatitis B: A Prospective Cohort Study in Iran
  6. Effect of autologous amniotic membrane and fluid on wound healing and complications of cesarean section: Study protocol of a factorial randomized controlled trial
  7. Determining the Safety and Effectiveness of ENDOR Oral Combination Drug in the Treatment of Patients With COVID-19: A Randomized Controlled Trial
  8. Advances in FDG PET imaging for staging and prognostic assessment in pediatric lymphoma: a systematic review
  9. Knowledge Translation for Practical Use of HIV Care
  10. Predictors Indicating the Need for Packed Red Cell Transfusion in Trauma Patients in a Referral Hospital in Tehran Iran
  11. Investigating Serum Antithyroglobulin Antibody Trend and Response to Treatment in Patients with Differentiated Thyroid Cancer
  12. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  13. A review on fungal surgical site infections: epidemiology, risk factors, main fungal agents, and prevention
  14. COVID-19 and its association with meteorological, climate, and environmental factors: An umbrella review
  15. Corrigendum to “COVID-19 and its association with meteorological, climate, and environmental factors: A systematic review”
  16. Examining the Validity and Objectivity of Publication in Scientific Research
  17. Trend of HIV Prevalence and Incidence in Iranian Prisons: The Need to Strengthen Harm Reduction Programs in Iran
  18. HAM-Index Instead of H-Index for Authors' Impact
  19. Metabolic mediators of the overweight’s effect on infertility in women with polycystic ovary syndrome
  20. Correction
  21. Brief communication: comparison of changes in metabolic parameters following antiretrovial therapy with treatment regimens containing tenofovir alafenamide and tenofovir disoproxil fumarate
  22. A Systematic Review of Migration in Latin America: Implications in Health and Infectious Diseases
  23. Effectiveness of exercise on sarcopenia in HIV patients: a systematic review of current literature
  24. Facilitators and Barriers to adherence to antiretroviral therapy among incarcerated people living with HIV in Iran: insights from a qualitative study
  25. Evaluation of bone mineral density and its influencing factors in patients infected with HIV under antiretroviral therapy
  26. Changes in sexual activities and risky sexual behaviors during the COVID-19 pandemic: A systematic review
  27. Conflict of Interest in Health Research Articles
  28. Addressing the Critical Issue of Suicide Among Medical Residents in Iran
  29. Prevalence of sexually transmitted infections and associated factors among male prisoners in Great Tehran Prison by active case finding
  30. Self-reported lifetime Hepatitis B virus testing, and vaccination uptake among people who inject drugs in Iran: a nationwide study in 2020
  31. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  32. A rapid review of the epidemiology and combating strategies of hepatitis C virus infection in Ghana
  33. ChatGPT in Healthcare Writing: Advantages and Limitations
  34. Uvulitis as a New Sign of COVID-19
  35. Prevalence and risk factors for HIV infection in truck drivers: a systematic review of global evidence
  36. Editorial: can the retraction of articles endanger the mental health of researchers?
  37. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
  38. Preparation, Characterization and In vitro Evaluation of Insulin-PHBV Nanoparticles/Alginate Hydrogel Composite System for Prolonged Delivery of Insulin
  39. The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
  40. Ethical Considerations for AI Use in Healthcare Research
  41. An empirical test of the chronic illness quality of life model: the prominent role of barrier to health care and social support
  42. The effectiveness of health‐related quality of life (HRQOL) model in people with HIV: A cross sectional study
  43. Can Waves of Autoimmune Diseases Occur after the COVID-19 Pandemic?
  44. Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review
  45. The prevalence of HTLV-1 co-infection among people living with HIV in a tertiary care hospital in Tehran: a cross-sectional study
  46. Mediating role of resilience in a relationship between social support and CD4 count of patients living with HIV in Behavioral Diseases Counseling Center of Imam Khomeini Hospital, Tehran
  47. Comparison of adrenalectomy with conservative treatment on mild autonomous cortisol secretion: a systematic review and meta-analysis
  48. Can Vaccination with Various Types of Vaccines Make Communities Safer against COVID-19?
  49. Evaluating the Relationship between Various Risk Factors and COVID-19 Incidence in People Living with HIV: A Cross-Sectional Study
  50. Prior COVID‐19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case‐control study
  51. Characteristics of children living with HIV in a referral center in Iran: a cross-sectional study
  52. Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
  53. A Systematic Review of Telehealth Applications in Endocrinology
  54. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  55. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  56. Estimating the Size of the Hidden Population of COVID-19
  57. Managing Hepatotoxicity Caused by Anti-tuberculosis Drugs: A Comparative Study of Approaches
  58. Important Risk Factors of Liver Cirrhosis in HIV and Hepatitis C Coinfected Patients: A Systematic Review
  59. Effect the pre-exposure prophylactic of hydroxychloroquine on severe COVID-19 disease: a randomized controlled trial
  60. Monkeypox: a systematic review of epidemiology, pathogenesis, manifestations, and outcomes
  61. Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in COVID-19 Patients: A Systematic Review of Current Evidence
  62. Ocular manifestations of COVID-19: A systematic review of current evidence
  63. The effect of macronutrient and micronutrient supplements on COVID-19: an umbrella review
  64. The prognostic significance of insulin resistance in COVID-19: a review
  65. The Upper-gastrointestinal Endoscopic Findings of People Living with HIV: A Systematic Review
  66. Prevalence of Erectile Dysfunction (ED) among People Living with HIV in Tehran, Iran
  67. The Challenges of ChatGPT in Healthcare Scientific Writing
  68. Violence among women living with HIV in Iran: prevalence and related risk factors
  69. Prevalence of hepatitis B infection in the Gambian population: A narrative review of recent developments
  70. An umbrella review on treatments and therapeutic options for COVID-19
  71. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review
  72. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review
  73. The relationship of hip fracture and thyroid disorders: a systematic review
  74. Job Burnout among Employees and Therapists in Counseling Centers for Behavioral Diseases in Iran
  75. Multiple Substance Use Patterns and Its Relationship with Imprisonment in a High-Risk Group of Iranian Adults
  76. Coping strategies and their correlation with depression, anxiety, and stress among HIV-positive patients referred to voluntary counseling and testing center, Tehran, Iran, 2019
  77. Seroprevalence and associated factors of hepatitis A IgG antibody among HIV-positive people in Tehran, Iran
  78. Social Avoidance and Emotional Deprivation of Healthcare Providers during the COVID-19 Pandemic
  79. Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial
  80. The Psychological, Philosophical, and Political Implications of COVID-19
  81. Post-Exposure Prophylaxis for COVID-19: A Systematic Review
  82. Retraction statement: Evaluating the effects of air disinfectants in decontamination of COVID‐19 aerosols
  83. Retraction statement: Mucormycosisco‐infection in patients with COVID‐19: A systematic review
  84. Retraction statement: Prevalence of sexually transmitted infections and associated ‎risk behaviors in prisoners: A systematic review
  85. Retraction statement: The relationship between CRP and levels of various cytokines in patients with ‎COVID‐19: A systematic review and correlation analysis
  86. Retraction statement: Gut microbiota and COVID‐19: A systematic review
  87. Physical and functional evaluations in oncological patients elective to medium and large operations
  88. Prevalence and complication of COVID‐19 in patients with ankylosing spondylitis (AS) and its relationship with TNF‐a inhibitors
  89. Personality Disorders in Patients with Human Immunodeficiency Virus
  90. Effects of Smoking on COVID-19 Management and Mortality: An Umbrella Review
  91. Sexual and reproductive history of female prisoners in Iran: a health care needs analysis
  92. Hearing loss and COVID-19: an umbrella review
  93. Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review
  94. The comparison of clinical, laboratory, and radiological findings in immunocompromised and immunocompetent patients with COVID‐19: A case‐control study
  95. A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus
  96. Is There a Role for Hyperbaric Oxygen Therapy in Reducing Long-Term COVID-19 Sequelae?
  97. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study
  98. Clinical and microbiological patterns in critically ill patients with catheter-associated UTI: A report from Iran
  99. Retracted: Gut microbiota and COVID‐19: A systematic review
  100. The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review
  101. Retracted: Evaluating the effects of air disinfectants in decontamination of COVID‐19 aerosols
  102. HIV self-testing in Iran: first implementation and feasibility study
  103. Social stigma during COVID-19: A systematic review
  104. Prevalence of sexually transmitted infections (STIs) and related factors among female prisoners in Tehran, Iran
  105. Prevalence of Hepatitis in Prisoners: A Systematic Review of Current Evidence
  106. Investigation of job satisfaction amongst voluntary, counseling and testing centers and health centers in Iran
  107. The relationship between cumulative dose of immunosuppressive agents and COVID‐19‐associated mucormycosis: A multicenter cross‐sectional study
  108. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review
  109. Retracted: The relationship between C‐reactive protein and levels of various cytokines in patients with COVID‐19: A systematic review and correlation analysis
  110. Plasma and semen viral loads discordance in HIV-positive patients receiving antiretroviral treatment (ART) in Tehran: an implication for a healthy pregnancy
  111. Effectiveness of social marketing on reducing risky sexual behaviors in HIV-positive individuals in Iran: a pilot randomized controlled trial
  112. Retracted: Prevalence of sexually transmitted infections and associated risk behaviors in prisoners: A systematic review
  113. Antimicrobial susceptibility testing of Staphylococcus aureus isolates from patients at a tertiary hospital in Tehran, Iran, 2018–2019
  114. Retracted: Design, development, and evaluation of a registry system for hyperbaric oxygen therapy: A methodological study
  115. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
  116. COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice
  117. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  118. The Value of Spiral Chest Computed Tomography Scan in the Diagnosis of Asymptomatic Coronavirus Carriers among Paranasal Sinus and Pharynx Surgery Candidates
  119. Comparison of SARS-CoV-2 (Coronavirus) with other Similar Viruses Based on Current Evidence
  120. Immediate and Long-Term Effects of a Computerized Cognitive Rehabilitation Therapy on Cognitive Function in People Living with HIV in Iran: A Single-Blind Two-Arm Parallel Randomized Controlled Trial
  121. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
  122. Technology in the Era of COVID-19: A Systematic Review of Current Evidence
  123. Spontaneous Loculated Pneumomediastinum in a COVID-19-Infected Patient
  124. Retracted: COVID‐19 mortality and its predictors in the elderly: A systematic review
  125. The post‐Omicron situation: The end of the pandemic or a bigger challenge?
  126. Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎
  127. Mobile applications in HIV self-management: A systematic review of scientific literature
  128. COVID-19 Reinfection or Relapse? A Retrospective Multicenter Cohort Study from Iran
  129. Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
  130. Retracted: Internet of things in the management of chronic diseases during the COVID‐19 pandemic: A systematic review
  131. Retracted: Mucormycosis infection in patients with COVID‐19: A systematic review
  132. Retracted: Impact of COVID‐19 pandemic on routine vaccination coverage of children and adolescents: A systematic review
  133. Retracted: Prenatal and neonatal complications of COVID‐19: A systematic review
  134. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
  135. Combined training improves the diagnostic measures of sarcopenia and decreases the inflammation in HIV‐infected individuals
  136. Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review
  137. Comparison of the Effectiveness of Positive Thinking Group Training and Acceptance and Commitment Therapy on Psychological Well-being and Risky Behaviors of Patients with HIV
  138. Mindfulness-Based Compassion-Focused Therapy and a Comparison of Effectiveness of Stress Reduction Program on Self-Compassion of HIV Positive Patients
  139. Comparison of the effectiveness of positive thinking training and acceptance and commitment therapy on quality of life and resilience of people living with HIV
  140. Developing Aysoo: a mobile-based self-management application for people living with HIV
  141. Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: A systematic review
  142. Prevalence and reasons of loss to follow-up in HIV clinics: a systematic review of current evidence
  143. Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
  144. The relationship between COVID‐19 viral load and disease severity: A systematic review
  145. COVID-19 and Alcohol Misuse: A Case Report
  146. Correction to: Predictors of the chest CT score in COVID‑19 patients: a cross‑sectional study
  147. Predictors of the chest CT score in COVID-19 patients: a cross-sectional study
  148. Mortality risk factors in kidney‐transplanted patients with COVID ‐19: A systematic review and regression analysis
  149. Identifying data elements and key features of a mobile-based self-care application for patients with COVID-19 in Iran
  150. Social Support Associated with Condom Use Behavior Among Female Sex Workers in Iran
  151. A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case Report
  152. COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases
  153. Postoperative COVID-19 Pneumonia in an Asymptomatic Patient: A Case Report
  154. Pulmonary Valve Endocarditis: A Case Report
  155. Transmission Modes of COVID-19: A Systematic Review
  156. Sociodemographic Characteristics, HIV-Related Risk Behaviors and HIV Prevalence of Vulnerable Men in Tehran, Iran
  157. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review
  158. Multifocal Osteolytic Lesions in Skull Bone with Mycobacterium Tuberculosis: A Case Report
  159. Security challenges and solutions using healthcare cloud computing
  160. The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence
  161. Distinguishing repeated polymerase chain reaction positivity from re‐infections in COVID‐19
  162. Can children of the Sputnik V vaccine recipients become symptomatic?
  163. Effects of COVID-19 prevention procedures on other common infections: a systematic review
  164. Cascade of care in people living with HIV in Iran in 2019; how far to reach UNAIDS/WHO targets
  165. Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report
  166. Bone Marrow Aspiration/Biopsy in the Evaluation of Fever of Unknown Origin in Patients with AIDS
  167. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review
  168. Genetic susceptibility of COVID-19: a systematic review of current evidence
  169. SARS-CoV-2 re-positivity within the first 3 months of COVID-19 recovery; probable re-infection
  170. Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
  171. NLRP3 and IL-1β Gene Expression Is Elevated in Monocytes From HIV-Treated Patients With Neurocognitive Disorders
  172. Behavioral and Clinical Characteristics and Outcomes of Treatment Among Older Patients Receiving Medical Care for HIV Infection in Iran
  173. SARS-CoV-2 Reinfection within the first 3 months of COVID-19 Recovery in A Referral Hospital, Tehran, Iran
  174. COVID-19 Re-infection or Relapse? A Retrospective Multi Center Cohort Study From Iran
  175. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
  176. Barriers to Antiretroviral Therapy Adherence in One of the Prisons in Iran
  177. Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison
  178. Granulomatosis with Polyangiitis (GPA) in a 15-year-old Girl with Facial Acne-like Ulcers: A Case Report
  179. Factors Associated with COVID-19 Morbidity and Mortality: A Narrative Review
  180. The Effect of First- and Second-Line Antiretroviral Therapies on Lipid Profile of HIV/AIDS Patients
  181. The prevalence and associated factors of adverse pregnancy outcomes among Afghan women in Iran; Findings from community-based survey
  182. Bacillary angiomatosis by Bartonella quintana in HIV-infected patient: molecular confirmed case in Iran
  183. Effect of green tea consumption in treatment of mild to moderate depression in Iranian patients living with HIV: A double-blind randomized clinical trial
  184. Effectiveness of mindfulness-based stress reduction training on resilience in Iranian HIV-positive women: a clinical trial
  185. Gaps and solutions of HIV testing, care, and treatment in Iran during 2018-2019
  186. HIV/HTLV-1 co-infection: a systematic review of current evidence
  187. Psychometric Properties Of Persian Version Of Patient Health Questionnaire (PHQ-9) In An Iranian HIV-Infected Patients
  188. Predictors of hospital mortality among patients with COVID-19 in Tehran, Iran
  189. Psychological symptoms of COVID-19 epidemic: A systematic review of current evidence
  190. Qualitative analysis of attitudes, behaviors, and demands of vulnerable men in Tehran, Iran
  191. Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report.
  192. Prevalence and Factors Associated with Hepatic Steatosis and Fibrosis Using Fibroscan in HIV-positive Patients Treated with Anti-retroviral (ARV) Medicines Referred to the Biggest Hospital in Tehran, 2018 to 2019
  193. The Relationships Between Early Maladaptive Schemas, Quality of Life and Self-care Behaviors in a Sample of Persons Living with HIV: The Potential Mediating Role of Cognitive Emotion Regulation Strategies
  194. Reinfection risk of novel coronavirus (CoVID-19): A systematic ‎review of current evidence
  195. Hepatitis A Seroprevalence Among Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study in Iran During 2016-2017
  196. Determinants of Needle Stick Injuries Among Healthcare Providers at a Tehran University Hospital in 2016: A Descriptive Report
  197. The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients
  198. Predictors of mortality in patients with COVID-19–a systematic review
  199. Combination of resistance and aerobic exercise for six months improves bone mass and physical function in HIV infected individuals: A randomized controlled trial
  200. HIV in Iran: onset, responses, and future directions
  201. The relationship between social roles and psychosocial adjustment in women with HIV: A structural equation model
  202. A systematic review of ECG findings in patients with COVID-19
  203. Prevalence of Cancers Among Patients with HIV Referring to Voluntary Counseling and Testing Center, Tehran, Iran, 2004-2017
  204. Efficacy and Safety of Arbidol in Treatment of Patients with COVID-19 Infection: A Randomized Clinical Trial
  205. Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment
  206. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case
  207. Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
  208. Epidemiology of HIV in Iran
  209. A mobile-based self-management application- usability evaluation from the perspective of HIV-positive people
  210. A study of barriers to adherence of antiretroviral treatment in prisoners living with HIV in Tehran, Iran
  211. The prevalence and associated factors of adverse pregnancy outcomes among Afghan women in Iran; the possible impacts of domestic violence, poor mental health, housing issues, and food security
  212. Superior Mesenteric Venous (SMV) Thrombosis Accompanied with Appendicitis in a Patient with Primary Diagnosis of Typhoid Fever
  213. Barriers and associated factors for adequate antenatal care among Afghan women in Iran; findings from a community-based survey
  214. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital
  215. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence
  216. EFFECT OF AEROBIC EXERCISE ON FLAT, DOWNHILL, AND UPHILL LEVEL ON SERUM LEVELS OF LEPTIN AND ADIPONECTIN IN CHRONIC OBSTRUVTIVE PULMINARY DISEASE PATIENTS
  217. Disseminated TB in an Immunocompetent Patient: A Case Report
  218. HIV and Risk Behaviors Among Visitors of Inmates at the Great Tehran Prison, Iran, 2018
  219. “It is good, but I can’t afford it …” potential barriers to adequate prenatal care among Afghan women in Iran: a qualitative study in South Tehran
  220. Health service provision for disease control among prisoners: a conceptual note
  221. Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
  222. Comparison of tuberculosis indicators after implementation of the clinical protocol for tuberculosis and HIV management in Iranian prisons: a quasi-experimental study
  223. Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report
  224. Determinants and barriers of adequate antenatal care among Afghan women in Iran; findings from a community-based survey in Iran
  225. Self-Care Instructions for People Not Requiring Hospitalization for Coronavirus Disease 2019 (COVID-19)
  226. The relationship between social roles and psychosocial adjustment in women with AIDS: A structural equation model
  227. “It is good, but I can’t afford it…” potential barriers to adequate prenatal care among Afghan women in Iran: a qualitative study in south Tehran
  228. Prospective and Retrospective Memory Complaints in HIV-Infected Individuals
  229. Isolated severe thrombocytopenia in a patient with COVID-19: A case report
  230. Prevalence of HIV-associated neurocognitive disorder (HAND) and its subgroups among HIV-positive persons on anti-retroviral therapy in Iran
  231. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19)
  232. Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran
  233. Effect of probiotic consumption on increasing the CD4+ T cell counts among Iranian patients living with HIV
  234. Green formulation of curcumin loaded lipid-based nanoparticles as a novel carrier for inhibition of post-angioplasty restenosis
  235. Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017)
  236. The HIV treatment cascade in people living with HIV in Iran in 2014: Mixed-method study to measure losses and reasons
  237. Content Analysis of Teleconsultation Enquiries in Positive Health Club, Imam Khomeini Hospital, Tehran, Iran
  238. Effect of a Short-term Lifestyle Modification Program on Quality of Life, Anthropometric Characteristics and CD4+T Cell Count of HIV Infected Patients in Tehran/Iran: A Randomized Controlled Trial
  239. Effect of 8 Weeks of Hospital-Based Resistance Training Program on TCD4+ Cell Count and Anthropometric Characteristic of Patients With HIV in Tehran, Iran: A Randomized Controlled Trial
  240. Effects of Aerobic Dance Training on Psychological Well-Being and Immune Function of Women Living With HIV
  241. National Commitments and Policy Instrument
  242. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients
  243. Association Between Immunologic and Virologic Functioning and Health-Related Quality of Life Among People Living with HIV, Tehran, Iran
  244. An Estimation of HIV/AIDS’s Cost in the Voluntary Counseling and Testing Center of Imam Khomeini Hospital in 2010-2011
  245. Preclinical and Clinical Safety and Efficacy of Faramir Treatment: A Novel Anti-Retroviral Drug
  246. Exploring and prioritization of mobile-based self-management strategies for HIV care
  247. HIV Prevalence and Correlations in Prisons in Different Regions of the World: A Review Article
  248. Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran
  249. Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus among HIV Positive Patients in Tehran, Iran
  250. Pseudomonas Aeruginosa Osteomyelitis of the Pubic Bone: A Case Report
  251. Prevalence of Tuberculosis in a Prison in Tehran by Active Case Finding
  252. Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study
  253. Common elements and features of a mobile-based self-management system for people living with HIV
  254. Comparing Tuberculosis Incidence in a Prison with the Society, Tehran, Iran
  255. John Cunningham virus large T antigen detection in brain biopsy of an HIV-infected patient with glioblastoma multiforme
  256. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation
  257. Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9–15 Months in 14 Triangular Clinics in Iran, 2015–2016
  258. Identifying and Validating Requirements of a Mobile-Based Self-Management System for People Living with HIV
  259. Mobile-Based Applications and Functionalities for Self-Management of People Living with HIV
  260. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran
  261. Revision and Implementation of “Clinical Guideline for Tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran
  262. Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
  263. Zika virus: A review of literature
  264. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran
  265. Frontiers in HIV Research
  266. Integration of HIV Services into Primary Health Care (PHC) System
  267. Management Model of Positive Clubs
  268. List of Contributors
  269. Subject Index
  270. Preface
  271. Demographic, Clinical and Laboratory Profiles of HIV Infected Patients Admitted into Imam Khomeini Hospital of Tehran, Iran
  272. Quickness of HIV and Tuberculosis Diagnostic Procedures in Prison of Tehran, Iran
  273. HIV-related risk behaviors among male inmates of Tehran, Iran
  274. Tuberculosis, hepatitis C and hepatitis B co-infections in patients with HIV in the Great Tehran Prison, Iran
  275. Impulsivity, Sensation Seeking, and Risk-Taking Behaviors among HIV-Positive and HIV-Negative Heroin Dependent Persons
  276. A follow-up program after prison release for HIV-positive patients
  277. “Evaluation of the Association between Addiction Severity Index and Depression with Adherence to Anti-retroviral Therapy among HIV Infected Patients”
  278. Perceived social support affects disease coping among people living with HIV: a study in Tehran, Iran
  279. Ebola viral disease: a review literature
  280. A new method to study knowledge, attitude and practice regarding HIV/AIDS in Iranian general population
  281. Psychological, social, and familial problems of people living with HIV/AIDS in Iran: A qualitative study
  282. Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa
  283. Problems of providing services to people affected by HIV/AIDS: service providers and recipients perspectives
  284. Addressing predictors of HIV related risk behaviors: Demographic and psychosocial profile of Iranian patients
  285. Subtype Classification of Iranian HIV-1 Sequences Registered in the HIV Databases, 2006-2013
  286. A study of the knowledge on HIV in regards to routes of transmission and sexual practices in men between the ages of 20 to 50 in Tehran
  287. Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran
  288. Mechanisms of Anti-retroviral Drug Resistance: Implications for Novel Drug Discovery and Development
  289. The effects of a social-cognitive method based education on knowledge and attitudes intentions with respect to HIV transmition among school learners in Maragheh, Iran
  290. Neurological manifestations in HIV positive patients in Tehran, Iran
  291. Impact of Age on CD4 Response to Combination Antiretroviral Therapy: A Study in Tehran, Iran
  292. Prevalence of HIV infection and the correlates among homeless in Tehran, Iran
  293. The effectiveness of discharge planning on the knowledge, clinical symptoms and hospitalisation frequency of persons with schizophrenia: a longitudinal study in two hospitals in Tehran, Iran
  294. Evaluation of Stigma Index Among People Living With HIV/AIDS (PLWHA) in Six Cities in Iran
  295. The emergence of drug resistant HIV variants and novel anti–retroviral therapy
  296. Post Marketing Surveillance on Safety and Efficacy of IMOD in Iranian Patients with HIV/AIDS
  297. Prevalence survey of infection with Treponema pallidum among HIV-positive patients in Tehran
  298. Prevalence of HIV infection and the correlates among beggars in Tehran, Iran
  299. Emerging HIV Drug Resistance in the Resource-Poor World: Challenges and Strategies
  300. Rheumatologic Manifestations Among HIV-positive Patients, Tehran, Iran
  301. Adherence to Anti-Retroviral Therapy and Its Determinants in HIV/AIDS Patients: A Review
  302. Tetanus in an unvaccinated child: A case report
  303. Prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infections among HIV infected people in Irans
  304. Adherence to Antiretroviral Therapy Among Iranian HIV/AIDS Patients
  305. Safety and Efficacy of Setarud (IMOD TM ) Among People Living with HIV/AIDS: A Review
  306. Prevalence of dermatologic manifestations among people living with HIV/AIDS in Imam Khomeini Hospital in Tehran, Iran
  307. Treatment with IMODTM as a Novel Immune Modulator in HIV Positive Patients
  308. Quality of Life among Persons with HIV/AIDS in Iran: Internal Reliability and Validity of an International Instrument and Associated Factors
  309. Randomized Controlled Trial of Mindfulness-Based Stress Reduction Delivered to Human Immunodeficiency Virus–Positive Patients in Iran
  310. Otolaryngological Manifestations in HIV Infected Patients, Tehran, Iran
  311. Post Marketing Surveillance on Safety and Efficacy of IMOD in Iranian Patients with HIV/AIDS
  312. Frequency of HIV Infection among Sailors in South of Iran by Rapid HIV Test
  313. Incidence of Mongolian Spots and its Common Sites at Two University Hospitals in Tehran, Iran
  314. Environmental risk factors for lung cancer in Iran: a case-control study
  315. Prevalence and Correlates of HIV Infection Among Male Injection Drug Users in Detention in Tehran, Iran
  316. Prevalence and Correlates of Hepatitis C Infection among Male Injection Drug Users in Detention, Tehran, Iran
  317. Environmental risk factors for lung cancer in Iran: a case-control study
  318. Vitiligo in a patient associated with human immunodeficiency virus infection and repigmentation under antiretroviral therapy
  319. HIV seroconversion among injection drug users in detention, Tehran, Iran
  320. Hirsutism
  321. Erectile Dysfunction in Diabetic Patients
  322. Novel Vascular Molecule Involved in Monocyte Adhesion to Aortic Endothelium in Models of Atherogenesis
  323. Arch Microbiology